Requirement of Vascular Integrin α v β 3 for Angiogenesis
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Angiogenesis depends on the adhesive interactions of vascular cells. The adhesion receptor integrin α v β 3 was identified as a marker of angiogenic vascular tissue. Integrin α v β 3 was expressed on blood vessels in human wound granulation tissue but not in normal skin, and it showed a fourfold increase in expression during angiogenesis on the chick chorioallantoic membrane. In the latter assay, a monoclonal antibody to α v β 3 blocked angiogenesis induced by basic fibroblast growth factor, tumor necrosis factor-α, and human melanoma fragments but had no effect on preexisting vessels. These findings suggest that α v β 3 may be a useful therapeutic target for diseases characterized by neovascularization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the integrin a v b 3 is expressed on blood vessels in human wound granulation tissue but not in normal skin”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
In the citing paper
“antibodies against this integrin block angiogenesis induced by FGF and TNF-a without affecting preexisting blood vessels”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [61]
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,775
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
Cheresh, D. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6471 · Cited by 561
Self-citationCell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.
Lawler, J., Weinstein, R., & Hynes, R. O. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2351 · Cited by 474
Adams, J. C., & Watt, F. M. (1990) · Cell · doi:10.1016/0092-8674(90)90175-e · Cited by 448
Gladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Self-citationLeavesley, D. I., Schwartz, M. A., Rosenfeld, M., & Cheresh, D. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.163 · Cited by 391
Self-citationInvolvement of integrin alpha V gene expression in human melanoma tumorigenicity.
Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., & Cheresh, D. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115811 · Cited by 378
Self-citation
Research works printed but not linked: 1
- FOLKMAN, J, SEMINARS CANCER BIOL 3: 65 (1992).
Cited by
Items 201–300 of 1,011
Skurk, C., Maatz, H., Kim, H.-S., Yang, J., Abid, M. R., Aird, W. C., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304736200 · Cited by 274
Augustin, H. G., Kozian, D. H., & Johnson, R. C. (1994) · BioEssays · doi:10.1002/bies.950161208 · Cited by 274
Bayless, K. J., Salazar, R., & Davis, G. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65038-9 · Cited by 273
Angiogenesis, Vasculogenesis, and Induction of Healing in Chronic Wounds
Bauer, S. M., Bauer, R. J., & Velazquez, O. C. (2005) · Vascular and Endovascular Surgery · doi:10.1177/153857440503900401 · Cited by 273
Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles
Anderson, S. A., Rader, R. K., Westlin, W. F., Null, C., Jackson, D., Lanza, G. M., Wickline, S. A., & Kotyk, J. J. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200009)44:3<433::aid-mrm14>3.0.co;2-9 · Cited by 271
Vascular endothelial growth factor and endometriotic angiogenesis
McLaren, J. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.1.45 · Cited by 269
Dellian, M., Witwer, B. P., Salehi, H. A., Yuan, F., & Jain, R. K. (1996) · Europe PMC (PubMed Central) · Cited by 268
Burke, P. A., DeNardo, S. J., Miers, L. A., Lamborn, K. R., Matzku, S., & DeNardo, G. L. (2002) · PubMed · Cited by 268
The Pathophysiology of Angiogenesis
Polverini, P. J. (1995) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411950060030501 · Cited by 267
Barrett, T., Brechbiel, M., Bernardo, M., & Choyke, P. L. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20991 · Cited by 266
Design of Nanoparticle-Based Carriers for Targeted Drug Delivery
Yu, X., Trase, I., Ren, M., Duval, K., Guo, X., & Chen, Z. (2016) · Journal of Nanomaterials · doi:10.1155/2016/1087250 · Cited by 265
Angiogenesis and invasion in glioma
Onishi, M., Ichikawa, T., Kurozumi, K., & Date, I. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-010-0007-z · Cited by 264
Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
Saaristo, A., Karpanen, T., & Alitalo, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203969 · Cited by 264
Cardiovascular ephrinB2 function is essential for embryonic angiogenesis
Gerety, S. S., & Anderson, D. J. (2002) · Development · doi:10.1242/dev.129.6.1397 · Cited by 263
Evidence of IL-18 as a Novel Angiogenic Mediator
Park, C. C., Morel, J. C. M., Amin, M. A., Connors, M. A., Harlow, L. A., & Koch, A. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1644 · Cited by 263
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01315.x · Cited by 263
Differential αv integrin–mediated Ras-ERK signaling during two pathways of angiogenesis
Hood, J. D., Frausto, R., Kiosses, W. B., Schwartz, M. A., & Cheresh, D. A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304105 · Cited by 262
Self-citationNoninvasive imaging of myocardial angiogenesis following experimental myocardial infarction
Meoli, D. F., Sadeghi, M. M., Krassilnikova, S., Bourke, B. N., Giordano, F. J., Dione, D. P., Su, H., Edwards, D. S., Liu, S., Harris, T. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420352 · Cited by 262
Template Assembled Cyclopeptides as Multimeric System for Integrin Targeting and Endocytosis
Boturyn, D., Coll, J., Garanger, É., Favrot, M., & Dumy, P. (2004) · Journal of the American Chemical Society · doi:10.1021/ja049926n · Cited by 262
Manipulating Angiogenesis: From Basic Science to the Bedside
Pepper, M. S. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.605 · Cited by 261
Tam, S. H., Sassoli, P. M., Jordan, R. E., & Nakada, M. T. (1998) · Circulation · doi:10.1161/01.cir.98.11.1085 · Cited by 260
Iliopoulos, O., Ohh, M., & Kaelin, W. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11661 · Cited by 260
Chen, X., Park, R., Tohme, M., Shahinian, A. H., Bading, J. R., & Conti, P. S. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0300403 · Cited by 260
Mechanism of action in thalidomide teratogenesis
Stephens, T. D., Bunde, C. J. W., & Fillmore, B. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00388-3 · Cited by 259
Invited review: activity-induced angiogenesis
Egginton, S. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0563-9 · Cited by 259
Varasteh, Z., Mohanta, S., Robu, S., Braeuer, M., Li, Y., Omidvari, N., Topping, G., Sun, T., Nekolla, S. G., Richter, A., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.226993 · Cited by 256
Integrins: The Keys to Unlocking Angiogenesis
Silva, R., D'Amico, G., Hodivala-Dilke, K. M., & Reynolds, L. E. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.172015 · Cited by 255
Cooperation between integrin ανβ3 and VEGFR2 in angiogenesis
Somanath, P. R., Malinin, N. L., & Byzova, T. V. (2009) · Angiogenesis · doi:10.1007/s10456-009-9141-9 · Cited by 254
Molecular basis of endothelial cell morphogenesis in three‐dimensional extracellular matrices
Davis, G. E., Bayless, K. J., & Mavila, A. (2002) · The Anatomical Record · doi:10.1002/ar.10159 · Cited by 253
Li, Z.-B., Cai, W., Cao, Q., Chen, K., Wu, Z., He, L., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.039859 · Cited by 251
New perspectives in clinical oncology from angiogenesis research
Folkman, J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00423-6 · Cited by 250
Hidai, C., Zupancic, T., Penta, K., Mikhail, A., Kawana, M., Quertermous, E. E., Aoka, Y., Fukagawa, M., Matsui, Y., Platika, D., et al. (1998) · Genes & Development · doi:10.1101/gad.12.1.21 · Cited by 247
Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles
Schmieder, A. H., Winter, P. M., Caruthers, S. D., Harris, T. D., Williams, T. A., Allen, J. S., Lacy, E. K., Zhang, H., Scott, M. J., Hu, G., et al. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20391 · Cited by 246
“The 3-integrin represents an attractive target for molecular imaging of tumor angiogenesis because expression is dramatically increased on neovasculature (14) but is not generally expressed on quiescent endothelial cells (15,16).”
BackgroundRole of Vitronectin and Its Receptors in Haemostasis and Vascular Remodeling
Preissner, K. T., & Seiffert, D. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(97)00298-3 · Cited by 245
Lafleur, M. A., Handsley, M. M., Knäuper, V., Murphy, G., & Edwards, D. R. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.17.3427 · Cited by 244
Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition
Das, A., & McGuire, P. G. (2003) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.08.001 · Cited by 242
Integrin Targeted Delivery of Chemotherapeutics
Chen, K., & Chen, X. (2011) · Theranostics · doi:10.7150/thno/v01p0189 · Cited by 242
The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer
Rodrigues, L. R., Teixeira, J. A., Schmitt, F. L., Paulsson, M., & Lindmark-Mänsson, H. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1008 · Cited by 242
Yebra, M., Parry, G. C. N., Strömblad, S., Mackman, N., Rosenberg, S., Mueller, B. M., & Cheresh, D. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29393 · Cited by 242
Self-citationBayless, K. J., & Davis, G. E. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1123 · Cited by 242
Tian, T., Cao, L., He, C., Ye, Q., Liang, R., You, W., Zhang, H., Wu, J., Ye, J., Tannous, B. A., et al. (2021) · Theranostics · doi:10.7150/thno.56367 · Cited by 240
MacDonald, T. J., Taga, T., Shimada, H., Tabrizi, P., Zlokovic, B. V., Cheresh, D. A., & Laug, W. E. (2001) · Neurosurgery · doi:10.1097/00006123-200101000-00026 · Cited by 240
Self-citationPhage Nanofibers Induce Vascularized Osteogenesis in 3D Printed Bone Scaffolds
Wang, J., Yang, M., Zhu, Y., Wang, L., Tomsia, A. P., & Mao, C. (2014) · Advanced Materials · doi:10.1002/adma.201400154 · Cited by 239
An Address System in the Vasculature of Normal Tissues and Tumors
Ruoslahti, E., & Rajotte, D. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.813 · Cited by 239
Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo
Cantarella, G., Lempereur, L., Presta, M., Ribatti, D., Lombardo, G., Lazarovici, P., Zappalà, G., Pafumi, C., & Bernardini, R. (2002) · The FASEB Journal · doi:10.1096/fj.01-1000fje · Cited by 238
The Role of αvβ3 in Prostate Cancer Progression
Cooper, C. R., Chay, C. H., & Pienta, K. J. (2002) · Neoplasia · doi:10.1038/sj.neo.7900224 · Cited by 238
Transient functional expression of alphaVbeta 3 on vascular cells during wound repair.
Clark, R. A. F., Tonnesen, M. G., Gailit, J. O., & Cheresh, D. A. (1996) · Europe PMC (PubMed Central) · Cited by 236
Self-citationTumor Targeting via Integrin Ligands
Marelli, U. K., Rechenmacher, F., Sobahi, T. R. A., Mas-Moruno, C., & Kessler, H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00222 · Cited by 236
Boron agents for neutron capture therapy
Hu, K., Yang, Z., Zhang, L., Xie, L., Wang, L., Xu, H., Josephson, L., Liang, S. H., & Zhang, M.-R. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.213139 · Cited by 236
Purushothaman, A., Uyama, T., Kobayashi, F., Yamada, S., Sugahara, K., Rapraeger, A. C., & Sanderson, R. D. (2010) · Blood · doi:10.1182/blood-2009-07-234757 · Cited by 234
Walsh, D. (1999) · Rheumatology · doi:10.1093/rheumatology/38.2.103 · Cited by 234
Targeted therapy for brain tumours
Lesniak, M. S., & Brem, H. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1414 · Cited by 234
Platelet and osteoclast β 3 integrins are critical for bone metastasis
Bakewell, S. J., Nestor, P., Prasad, S., Tomasson, M. H., Dowland, N., Mehrotra, M., Scarborough, R., Kanter, J., Abe, K., Phillips, D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234372100 · Cited by 233
Targeted imaging using ultrasound
Dayton, P. A., & Ferrara, K. W. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10173 · Cited by 233
Wilder, R. L. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii96 · Cited by 232
A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis
Yi, M., & Ruoslahti, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.620 · Cited by 232
Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties
Maeshima, Y., Colorado, P. C., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000186200 · Cited by 231
Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin
Maeshima, Y., Manfredi, M., Reimer, C., Holthaus, K. A., Hopfer, H., Chandamuri, B. R., Kharbanda, S., & Kalluri, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007764200 · Cited by 230
Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., & Nakamura, T. (2000) · PubMed · Cited by 230
Kim, J.-H., Kim, Y.-S., Park, K., Kang, E., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Chi, D. Y., Park, R.-W., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.038 · Cited by 228
Davis, G. E., Allen, K. A. P., Salazar, R., & Maxwell, S. A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.917 · Cited by 228
Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
Mukhopadhyay, S., Barnés, C. M., Haskel, A., Short, S. M., Barnes, K. R., & Lippard, S. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc070031k · Cited by 226
Eskens, F. A. L. M., Dumez, H., Hoekstra, R., Perschl, A., Brindley, C., Böttcher, S., Wynendaele, W., Drevs, J., Verweij, J., & van Oosterom, A. T. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00057-1 · Cited by 225
α v β 3 Integrin Expression in Normal and Atherosclerotic Artery
Hoshiga, M., Alpers, C. E., Smith, L. L., Giachelli, C. M., & Schwartz, S. M. (1995) · Circulation Research · doi:10.1161/01.res.77.6.1129 · Cited by 225
Mechanisms and Future Directions for Angiogenesis-Based Cancer Therapies
Scappaticci, F. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.033 · Cited by 225
Forty-Year Journey of Angiogenesis Translational Research
Cao, Y., Arbiser, J., D’Amato, R. J., D’Amore, P. A., Ingber, D. E., Kerbel, R., Klagsbrun, M., Lim, S., Moses, M. A., Zetter, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003149 · Cited by 223
Markers for Microscopic Imaging of Lymphangiogenesis and Angiogenesis
Baluk, P., & McDonald, D. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.001 · Cited by 222
Sasaki, T., Larsson, H., Tisi, D., Claesson-Welsh, L., Hohenester, E., & Timpl, R. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3996 · Cited by 220
Maskevich, A. A., Stsiapura, V. I., Kuzmitsky, V. A., Kuznetsova, I. M., Povarova, O. I., Uversky, V. N., & Turoverov, K. K. (2007) · Journal of Proteome Research · doi:10.1021/pr0605567 · Cited by 220
Anderson, C. R., Hu, X., Zhang, H., Tlaxca, J., Declèves, A.-E., Houghtaling, R., Sharma, K., Lawrence, M., Ferrara, K. W., & Rychak, J. J. (2011) · Investigative Radiology · doi:10.1097/rli.0b013e3182034fed · Cited by 219
“A principal marker of the angiogenic phenotype is v 3 integrin, which is constitutively expressed in low levels in quiescent endothelial cells and highly upregulated during angiogenesis.(3) The v 3 integrin binds arginine-glycine-aspartic acid (RGD) sequences of provisional matrix proteins such as vitronectin and fibr…”
BackgroundOsada, K., Christie, R. J., & Kataoka, K. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0547.focus · Cited by 218
Molecular Imaging of Cardiovascular Disease
Jaffer, F. A., Libby, P., & Weissleder, R. (2007) · Circulation · doi:10.1161/circulationaha.106.647164 · Cited by 218
Beer, A. J., Grosu, A.-L., Carlsen, J., Kolk, A., Sarbia, M., Stangier, I., Watzlowik, P., Wester, H.-J., Haubner, R., & Schwaiger, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0528 · Cited by 217
Antiangiogenic Therapy for Cancer: An Update
Al‐Husein, B., Abdalla, M., Trepte, M., DeRemer, D. L., & Somanath, P. R. (2012) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1147 · Cited by 216
Garmy-Susini, B., Jin, H., Zhu, Y., Sung, R.-J., Hwang, R., & Varner, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23445 · Cited by 216
Kim, S., Harris, M., & Varner, J. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003668200 · Cited by 216
Foot-and-Mouth Disease Virus Virulent for Cattle Utilizes the Integrin α v β 3 as Its Receptor
Neff, S., Sá-Carvalho, D., Rieder, E., Mason, P. W., Blystone, S. D., Brown, E. J., & Baxt, B. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3587-3594.1998 · Cited by 216
Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management
Almeida-Marrero, V., van de Winckel, E., Anaya-Plaza, E., Torres, T., & de la Escosura, A. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00554g · Cited by 216
ECM Remodeling Regulates Angiogenesis: Endothelial Integrins Look for New Ligands
Stupack, D. G., & Cheresh, D. A. (2002) · Science's STKE · doi:10.1126/stke.2002.119.pe7 · Cited by 215
Self-citationWeller, G. E. R., Wong, M. K. K., Modzelewski, R. A., Lu, E., Klibanov, A. L., Wagner, W. R., & Villanueva, F. S. (2005) · Cancer Research · doi:10.1158/0008-5472.533.65.2 · Cited by 215
Isogai, C., Laug, W. E., Shimada, H., Declerck, P. J., Stins, M. F., Durden, D. L., Erdreich‐Epstein, A., & DeClerck, Y. A. (2001) · PubMed · Cited by 215
VE-Cadherin Mediates Endothelial Cell Capillary Tube Formation in Fibrin and Collagen Gels1
Bach, T. L., Barsigian, C., Chalupowicz, D. G., Busler, D., Yaen, C. H., Grant, D. S., & Martinez, J. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3844 · Cited by 214
A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth
Yan, X. (2003) · Blood · doi:10.1182/blood-2002-04-1004 · Cited by 214
Biology of Angiogenesis and Invasion in Glioma
Tate, M. C., & Aghi, M. K. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.04.001 · Cited by 213
Between molecules and morphology. Extracellular matrix and creation of vascular form.
Vernon, R. B., & Sage, E. H. (1995) · Europe PMC (PubMed Central) · Cited by 213
Multifunctional Nanoemulsion Platform for Imaging Guided Therapy Evaluated in Experimental Cancer
Gianella, A., Jarzyna, P. A., Mani, V., Ramachandran, S., Calcagno, C., Tang, J., Kann, B., Dijk, W. J. R., Thijssen, V. L., Griffioen, A. W., et al. (2011) · ACS Nano · doi:10.1021/nn103336a · Cited by 212
Sasaki, T., Larsson, H., Kreuger, J., Salmivirta, M., Claesson-Welsh, L., Lindahl, U., Hohenester, E., & Timpl, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6240 · Cited by 211
“…inhibition of angiogenesis induced by FGF-2 and VEGF Angiogenesis in the chorioallantoic membrane (CAM) is efficiently induced by different cytokines and phorbol esters, making it a suitable model to examine the effect of angiogenesis inhibitors (Brooks et al., 1994; Friedlander et al., 1995).”
BackgroundMethodOda, N., Abe, M., & Sato, Y. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199902)178:2<121::aid-jcp1>3.0.co;2-f · Cited by 211
Augustin, H. G., Braun, K., Telemenakis, I., Modlich, U., & Kühn, W. (1995) · Europe PMC (PubMed Central) · Cited by 211
Nanotherapeutics relieve rheumatoid arthritis
Yang, M., Feng, X., Ding, J., Chang, F., & Chen, X. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.032 · Cited by 211
Angiogenic properties of human immunodeficiency virus type 1 Tat protein.
Albini, A., Barillari, G., Benelli, R., Gallo, R. C., & Ensoli, B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4838 · Cited by 210
Serum amyloid A1: Structure, function and gene polymorphism
Sun, L., & Ye, R. D. (2016) · Gene · doi:10.1016/j.gene.2016.02.044 · Cited by 210
Angiogenesis, vascular endothelial growth factor and the endometrium
Smith, S. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.509 · Cited by 209
Induction of the Angiogenic Phenotype by Hox D3
Boudreau, N., Andrews, C., Srebrow, A., Ravanpay, A., & Cheresh, D. A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.257 · Cited by 208
Self-citationαvβ3 and αvβ5 integrin antagonists inhibit angiogenesis in vitro
Nisato, R. E., Tille, J.-C., Jonczyk, A., Goodman, S. L., & Pepper, M. S. (2003) · Angiogenesis · doi:10.1023/b:agen.0000011801.98187.f2 · Cited by 207
Extracellular Matrix-derived Peptide Binds to αvβ3 Integrin and Inhibits Angiogenesis
Maeshima, Y., Yerramalla, U. L., Dhanabal, M., Holthaus, K. A., Barbashov, S., Kharbanda, S., Reimer, C., Manfredi, M., Dickerson, W. M., & Kalluri, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103024200 · Cited by 207
Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma
Müller, D. W., & Bosserhoff, A.-K. (2008) · Oncogene · doi:10.1038/onc.2008.282 · Cited by 206
Integrin signaling is critical for pathological angiogenesis
Mahabeleshwar, G. H., Feng, W., Phillips, D. R., & Byzova, T. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060807 · Cited by 206
Integrins and angiogenesis: A sticky business
SERINI, G., VALDEMBRI, D., & BUSSOLINO, F. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.020 · Cited by 206
Reardon, D. A., Nabors, L. B., Stupp, R., & Mikkelsen, T. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.8.1225 · Cited by 206
Metadata
- Authors
- Brooks, P. C., Clark, R. A. F., & Cheresh, D. A.
- Affiliations
- Scripps Research Institute (US)
- Stony Brook University (US)
- Venue
- Science
- Published
- 1994-04-22
- Volume
- 264
- Issue
- 5158
- Pages
- 569-571
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029773366
- Cited by
- 3,020
- References
- 22
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 50 · 2023: 36 · 2022: 57 · 2021: 60 · 2020: 54 · 2019: 60 · 2018: 69 · 2017: 62 · 2016: 91 · 2015: 74 · 2014: 102 · 2013: 124 · 2012: 104
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-50286, CA-45726, R01CA045726)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- integrin αvβ3, angiogenesis, chorioallantoic membrane, basic fibroblast growth factor, TNF-α, melanoma, monoclonal antibodies, neovascularization, therapeutic target
- MeSH terms
- Animals, Antibodies, Monoclonal, Blood Vessels, Chick Embryo, Granulation Tissue, Humans, Laminin, Melanoma, Neovascularization, Pathologic, Skin, Tumor Necrosis Factor-alpha, von Willebrand Factor, Integrins, Receptors, Cytoadhesin, Fibroblast Growth Factor 2, Receptors, Vitronectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.